Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19

Ann Rheum Dis. 2020 Dec;79(12):1661-1663. doi: 10.1136/annrheumdis-2020-218009. Epub 2020 Jun 24.

Authors

Panayiotis G Vlachoyiannopoulos¹, Eleni Magira², Haris Alexopoulos¹, Edison Jahaj², Katerina Theophilopoulou¹, Anastasia Kotanidou², Athanasios G Tzioufas³

Affiliations

¹ Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Attica, Greece.
² 1st Department of Intensive Care Medicine, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Attica, Greece.
³ Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Attica, Greece agtzi@med.uoa.gr.

PMID: 32581086
DOI: 10.1136/annrheumdis-2020-218009

No abstract available

Keywords: autoantibodies; autoimmunity; inflammation.

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Anti-Citrullinated Protein Antibodies / immunology
Antibodies, Anticardiolipin / immunology
Antibodies, Antineutrophil Cytoplasmic / immunology
Antibodies, Antinuclear / immunology
Antigens, Nuclear / immunology
Autoantibodies / immunology*
Autoimmune Diseases / immunology
Betacoronavirus
COVID-19
Coronavirus Infections / immunology*
Coronavirus Infections / mortality
DNA / immunology
Female
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral / immunology*
Pneumonia, Viral / mortality
Rheumatic Diseases / immunology
SARS-CoV-2
Severity of Illness Index
beta 2-Glycoprotein I / immunology

Substances

Anti-Citrullinated Protein Antibodies
Antibodies, Anticardiolipin
Antibodies, Antineutrophil Cytoplasmic
Antibodies, Antinuclear
Antigens, Nuclear
Autoantibodies
beta 2-Glycoprotein I
DNA